After several years of events that have explored many facets of cell and gene therapy, PDA is continuing our commitment to the future of the pharmaceutical industry. This Conference will be an ideal forum for sharing best practices and learning how industry is applying novel approaches to product development, manufacturing, and regulatory compliance for long-term success. 

The Conference will start off strong with a keynote from Peter Marks, MD, PhD, Director, CBER, U.S. FDA, on Global Regulatory Convergence for ATMPs. 

Sessions throughout the Conference will explore: 

  • Next generation processing
  • Analytical methods
  • Quality systems implementation
  • Control strategy and its link to product realization
  • Quality risk management
  • Aseptic processing
  • Regulatory compliance

For the 2020 Edition of Advanced Therapy Medicinal Products, PDA and its ATMPs Program Planning Committees are using a format that will truly bring together the international community. The two-day conference will be hosted at two venues in parallel: in Brussels, Belgium and in Washington, DC. 

Connected to both events through select live simulcast sessions, you will have the opportunity to gain insights into the latest research and development highlighting the challenges and future impact of ATMPs from a global perspective. 

And, join us on June 23 for a pre-Conference Workshop focused on Cell Therapy Control Strategy.